34 results
10-K
2023 FY
EX-4.5
ZVRA
Zevra Therapeutics Inc
Annual report
1 Apr 24
5:27pm
8-K
EX-4.1
ZVRA
Zevra Therapeutics Inc
20 Nov 23
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
7:36am
10-K
2022 FY
EX-4.5
ZVRA
Zevra Therapeutics Inc
Annual report
7 Mar 23
5:26pm
10-K
2021 FY
EX-4.5
ZVRA
Zevra Therapeutics Inc
Annual report
30 Mar 22
5:54pm
S-3
EX-4.4
ZVRA
Zevra Therapeutics Inc
Shelf registration
2 Jul 21
4:31pm
S-8
EX-4.8
87uo9engkqkjy26 axmo
25 Jun 21
Registration of securities for employees
4:44pm
S-8
EX-4.5
s4p msfjbgkjsbacj
25 Jun 21
Registration of securities for employees
4:44pm
8-K
EX-4.1
5r1kf6
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-4.1
gje3twqvg8pge9nc0
26 Jan 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-4.3
ik22au1
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
8-K
EX-4.4
daga5t
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
POS EX
EX-4.11
r8ru6bl exfjmfdvtphk
8 Jan 21
Additional exhibits for listing
12:00am
POS EX
EX-4.10
g8o2klq8o2bbi
8 Jan 21
Additional exhibits for listing
12:00am